News About: Pharm. Industry
Abbott offers to lower price of antiretroviral Kaletra in Thailand
Abbott Laboratories agreed in principle to lower the price of its antiretroviral drug Kaletra in response to Thailand's announcement in January that it would issue a compulsory license for the drug, according to an of...
Civic groups call for more access to expensive drugs
Civic groups staged a protest rally to oppose Abbott Laboratories’ improper pressure on Thai government on April 26, demanding that people should have easier access to innovative drugs.
Members of civic groups crit...
Coenzyme Q10,propolis under spotlight
Coenzyme Q10 andpropolis, often categorized as functional health food materials, are riding high in the domestic pharmaceutical market.
These materials have been under the spotlight as drug makers, such as United ...
Festival for cervical cancer elimination by GSK and Ob & Gyn society.
The Korea Society of Obstetric and Gynecology (KSOG) announced to have "Women Festival for Cervical Cancer Elimination" at Techno-Mart CGV on May 6 sponsored by GSK, for the purpose of giving correct understanding abo...
Top 10 prescription drugs sold at over 200 billion won.
In the prescription drug markets in 2006 the top 50 companies included 30 domestic and 20 foreign drug corporations, and the top 10 included 5 domestic corporations including Hanmi, overall showing a balance between l...
Delay of positive list system is best FTA policy
Recently, Moon Kyung-tae, vice chairman of the Korea Pharmaceutical Manufacturers Association contributed the following articles to a local paper. - Ed.
Although its too early to tell who got the better end of the ...
Daewon to release new anti-osteoarthritis drug
Daewon Pharm said on April 23 that its home-grown Peluvi tablets (felubiprofen), new NSAID (nonsteroidal anti-inflammatory drug) for treatment of osteoarthritis, was approved by the Korea Food and Drug Administration....
Yuyu wins patent for new diabetic agent
Yuyu and CrystalGenomics announced on April 24 the acquisition of the local patent to cover a novel diabetic medication.
The patent invention relates to an inhibitor of glycogen synthase kinase-3 (GSK-3), its manuf...
Bayer Healthcare to launch an emergent contraceptive pill.Bayer Healthcare (Bayer Schering Pharma) has launched Postino-1, an emergent oral contraceptive pill to add a full pipeline of contraceptive products including an oral pill, IUD...
|
Sanofi-Aventis Korea launches 24-hour blood pressure measurement campaign
Sanofi-Aventis Korea has unveiled its new campaign to raise awareness about hypertension (high blood pressure), a leading cause of heart disease and stroke.
As part of its efforts to encourage blood pressure manage...
